SEC EDGAR Filing Information

Form SC 13G -- Statement of acquisition of beneficial ownership by individuals

Filing Date Changed: 2007-01-12
Documents: 1

SEC Accession No.
0000950162-07-000035
Filing date: 2007-01-12
Accepted: 2007-01-12 16:02:26

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13G	sigmatauamerica13g_010307.htm	334752	DOR BIOPHARMA/SIGMA TAU AMERICA S.A. - SCHEDULE 13G - 01/03/07

		0000950162-07-000035.txt	336869	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Subject) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 07528838
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131
305-534-3383

Mailing Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131

Sigma-Tau America S.A. (Filed by) (0001385930)
IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G | Act: | Film No.:

Business Address
19-21, BOULEVARD DU PRINCE HENRI
L-1724 LUXEMBOURG N4 00000
1-800-447-0169

Mailing Address
19-21, BOULEVARD DU PRINCE HENRI
L-1724 LUXEMBOURG N4 00000